UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Comprehensive Income	Retained Earnings	Total
Equity Balance, value at Dec. 31, 2022	$ 36	$ 251	$ (12,039)	$ 126,006	$ 114,254
Equity Balance, shares at Dec. 31, 2022	3,628
Common stock issued upon exercise of employee stock options	$ 0	117	0	0	117
Common stock issued upon exercise of employee stock options, shares	2
Stock option compensation expense	$ 0	153	0	0	153
Foreign currency translation adjustment	0	0	41	0	41
Common stock dividends	0	0	0	(3,212)	(3,212)
Net income	0	0	0	12,349	12,349
Equity Balance, value at Sep. 30, 2023	$ 36	521	(11,999)	135,144	123,702
Equity Balance, shares at Sep. 30, 2023	3,630
Equity Balance, value at Jun. 30, 2023	$ 36	432	(10,986)	132,279	121,762
Equity Balance, shares at Jun. 30, 2023	3,629
Common stock issued upon exercise of employee stock options	$ 0	36	0	0	36
Common stock issued upon exercise of employee stock options, shares	1
Stock option compensation expense	$ 0	53	0	0	53
Foreign currency translation adjustment	0	0	(1,012)	0	(1,012)
Common stock dividends	0	0	0	(1,071)	(1,071)
Net income	0	0	0	3,935	3,935
Equity Balance, value at Sep. 30, 2023	$ 36	521	(11,999)	135,144	123,702
Equity Balance, shares at Sep. 30, 2023	3,630
Equity Balance, value at Dec. 31, 2023	$ 36	593	(10,658)	138,341	128,313
Equity Balance, shares at Dec. 31, 2023	3,630
Common stock issued upon exercise of employee stock options	$ 0	390	0	0	390
Common stock issued upon exercise of employee stock options, shares	8
Stock option compensation expense	$ 0	184	0	0	184
Common stock purchased and retired	$ (2)	(1,168)	0	(12,090)	(13,259)
Common stock purchased and retired, shares	(197)
Foreign currency translation adjustment	$ 0	0	769	0	769
Common stock dividends	0	0	0	(3,171)	(3,171)
Net income	0	0	0	10,972	10,972
Equity Balance, value at Sep. 30, 2024	$ 34	0	(9,890)	134,053	124,197
Equity Balance, shares at Sep. 30, 2024	3,441
Equity Balance, value at Jun. 30, 2024	$ 35	0	(11,322)	135,339	124,052
Equity Balance, shares at Jun. 30, 2024	3,499
Stock option compensation expense	$ 0	53	0	0	53
Common stock purchased and retired	$ (1)	(53)	0	(3,812)	(3,866)
Common stock purchased and retired, shares	(58)
Foreign currency translation adjustment	$ 0	0	1,432	0	1,432
Common stock dividends	0	0	0	(1,038)	(1,038)
Net income	0	0	0	3,563	3,563
Equity Balance, value at Sep. 30, 2024	$ 34	$ 0	$ (9,890)	$ 134,053	$ 124,197
Equity Balance, shares at Sep. 30, 2024	3,441